Delivery Order SPE2DB24D2003-SPE2DB25FXCW7

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has a ceiling value of $3,063.57 and a performance period through March 25, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract has a ceiling value of $5,260.00 and a period of performance ending on May 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 2.5 mg/0.5 mL pens. The contract has a ceiling value of $23,188.94 and runs through July 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,520.00 firm fixed-price contract is for the supply of Mounjaro 12.5 mg/0.5 ml pens, a specialty medication. The contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $18,358.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a $999,999,999 contract vehicle that provides a comprehensive range of pharmaceutical products and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The contract, valued at $4,363.31, is for the supply of Mounjaro 10 mg/0.5 ml pens to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corporation, which has a potential value of $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has a firm fixed price of $1,486.06 and a performance period running through January 15, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,578 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,768,520 units of the medication Mounjaro 15 mg/0.5 ml pen. The period of performance runs through September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025. AmerisourceBergen, one of the largest...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,665.10 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has a completion date of November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $8,036.23, is for the provision of Mounjaro 2.5 mg/0.5 ml pens. This delivery order contract is associated with a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXCW7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 10 mg/0.5 ml pens. The $22,755.29 firm-fixed-price contract has an ultimate completion date of October 18, 2024. This contract appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, vaccines, and other critical medical commodities, to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition.

Generated 1/16/25, 9:11 AM